New COVID drug passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new drug called PA-001 in 47 healthy adults and older adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo through an IV. The goal was to find the right dose for future studies in COVID-19 pa…
Phase: PHASE1 • Sponsor: PeptiDream Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC